1. Home
  2. PLCE vs MXCT Comparison

PLCE vs MXCT Comparison

Compare PLCE & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Children's Place Inc. (The)

PLCE

Children's Place Inc. (The)

HOLD

Current Price

$4.82

Market Cap

160.3M

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.43

Market Cap

160.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLCE
MXCT
Founded
1969
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.3M
160.0M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
PLCE
MXCT
Price
$4.82
$1.43
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$4.50
$7.50
AVG Volume (30 Days)
857.0K
619.1K
Earning Date
12-16-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,288,160,000.00
$34,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.34
$10.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.66
$1.26
52 Week High
$11.99
$5.20

Technical Indicators

Market Signals
Indicator
PLCE
MXCT
Relative Strength Index (RSI) 41.59 39.17
Support Level $3.91 $1.48
Resistance Level $4.12 $1.59
Average True Range (ATR) 0.30 0.07
MACD 0.15 -0.01
Stochastic Oscillator 66.32 4.55

Price Performance

Historical Comparison
PLCE
MXCT

About PLCE Children's Place Inc. (The)

Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: